PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

NCT03671967 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1084

Enrollment

OTHER

Sponsor class

Conditions

Beta Lactam Resistant Bacterial Infection
Enterobacteriaceae Infections
Bacteremia

Interventions

DRUG: Piperacillin/tazobactam
DRUG: Meropenem

Sponsor

Rambam Health Care Campus

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]